SCRC Shareholders : > ......Huge Kaboom News out t
Post# of 7769
Posted On: 07/07/2014 8:37:49 AM
SCRC Shareholders : > ......Huge Kaboom News out this morning!!!.....ScripsAmerica Inc. takes in 2.7 million in revenue on one business operation!!!....Mr.Bob Schneiderman and his hard working team is about to take this company and its shareholders to new heights un-imaginable people!!! > ...IT IS NOW OFFICALLY OUR TIME NOW!!!......July 7, 2014 - 8:30 AM EDT
ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
TYSONS CORNER, VA--(Marketwired - Jul 7, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.
'Main Avenue Pharmacy,' which specializes in prescription topical pain creams, recorded an increase of 69% in approved orders from May to June, topping the 67% revenue growth during the previous month. Since ScripsAmerica entered an agreement to manage Main Avenue Pharmacy in mid-February 2014, the pharmacy's annual run rate has increased from $6 million to $32 million.
Commenting on the growth of ScripsAmerica's managed compounding pharmacy, CEO Bob Schneiderman said, "We are happy to report a sustained high growth rate for our specialty pharmacy in June and expect our monthly revenue to potentially increase again in July. The Company will continue to build on the success of Main Avenue Pharmacy moving forward as this has become a steady, significant revenue source for ScripsAmerica and its shareholders."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
TYSONS CORNER, VA--(Marketwired - Jul 7, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.
'Main Avenue Pharmacy,' which specializes in prescription topical pain creams, recorded an increase of 69% in approved orders from May to June, topping the 67% revenue growth during the previous month. Since ScripsAmerica entered an agreement to manage Main Avenue Pharmacy in mid-February 2014, the pharmacy's annual run rate has increased from $6 million to $32 million.
Commenting on the growth of ScripsAmerica's managed compounding pharmacy, CEO Bob Schneiderman said, "We are happy to report a sustained high growth rate for our specialty pharmacy in June and expect our monthly revenue to potentially increase again in July. The Company will continue to build on the success of Main Avenue Pharmacy moving forward as this has become a steady, significant revenue source for ScripsAmerica and its shareholders."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼